Glaxosmithkline plc: GSK files Shingrix 18+ at risk indication in Japan
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameGSK PLC
-
Registration countryUnited Kingdom
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









